Colorectal cancer incidence is increasing among young adults
the ONA take:
Screening efforts have resulted in an overall decrease in incidence of colorectal cancer (CRC). However, incidence of the disease in young adults (ages 20-39 years) has increased in the past 20 to 30 years.
Little is known about CRC incidence in young adults because recommended screening for people of average risk person begins at age 50 years. Researchers at the University of California, Irvine, analyzed 231,544 CRC cases from 1988-2009 from the California Cancer Registry to identify high-risk subgroups.
Their study cases included 5,617 young adults ages 20-39 years. Although the absolute incidence of CRC per 100,000 in this group was low, the researchers found CRC incidence increasing over time among both males and females, particularly for distal colon cancer in Hispanic females ages 20-29 years.
The researchers conclude that absolute incidence of CRC is significantly lower in among the young adult populations; however, incidence is increasing among young adults compared with the older screened population. They also note a need for further research to better characterize young adults at increased risk for CRC.
Incidence of colorectal cancer in young adults has increased in the past 20 to 30 years.
Sign Up for Free e-newsletters
- Risk Factors for Arterial, Venous Thrombosis Differ in Polycythemia Vera
- Patient Satisfaction Ratings Can Be Negatively Impacted by Nurse Staffing Ratio
- Dietary Estrogens Reduced Efficacy of Novel Breast Cancer Therapy
- BRCA Mutation Improves Prognosis for 2-year Survival in Younger-onset TNBC
- Fosfomycin Effective Alternate for Febrile Neutropenia Prophylaxis
- Pertuzumab Regimen Approved for Adjuvant, Neoadjuvant Therapy in Specific Breast Cancers
- Common Oncologic Emergencies That Occur With Multiple Myeloma
- Artificial Sweeteners and Cancer Risk (Fact Sheet)
- Blueberry Extract May Boost Efficacy of Radiotherapy for Cervical Cancer
- Breast Implants Associated With Increased Risk of Breast Anaplastic Large-cell Lymphoma
- Survival Outcomes in Relapsed Hepatocellular Carcinoma Improved With Cabozantinib
- OS Similar With Gemcitabine Plus S-1 vs Standard Therapy for Biliary Tract Cancer
- Feasibility and Outcomes of Modified Enhanced Recovery After Surgery for Nursing Management of Aged Patients Undergoing Esophagectomy
- Urine Drug Testing Policy Can Assist Opioid Treatment Decisions
- Resolving Vaginal Dryness in Women With a History of Breast Cancer
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|